Orthopedic Use of BPC 157 Sports Med Review HIMS: Regulatory Arbitrage and the Future of Personalized Medicine Big news for mens health. The FDA is officially advancing 12 high demand peptides including BPC 157, GHK Cu, and TB500 toward the next phase this July clearing the path for broader access and renewed FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Is BPC 157 Banned? Oral vs. Injectable Forms Explained